Creative Touch Permanent Makeup and Aesthetics

Every skin cell contains an autonomous molecular clock – but that clock does not run on genetics alone. The CLOCK:BMAL1 complex that drives the circadian transcription-translation feedback loop simultaneously drives production of NAMPT, the rate-limiting enzyme in the NAD⁺ salvage pathway, creating a 24-hour oscillation in cellular NAD⁺ levels. SIRT1, the NAD⁺-dependent deacetylase that regulates core clock proteins BMAL1 and PER2, uses this oscillating NAD⁺ supply to sustain the precision and amplitude of the clock itself. The feedback is genuinely interlocked: the clock makes NAD⁺, NAD⁺ fuels SIRT1, and SIRT1 sustains the clock that started the cycle. When metabolic inflexibility creates the Randle Cycle impasse – high glucose and high fat simultaneously generating NADH accumulation and reducing the NAD⁺/NADH ratio – the supply of NAD⁺ that SIRT1 requires contracts. Clock amplitude dampens from inside its own feedback loop. Ceramide synthesis loses its nighttime phase-gate. The precise temporal sequencing of collagen synthesis, secretion, and cross-linking assembly across the day-night cycle breaks down. Feeding timing compounds this through a distinct and independent mechanism: restricted feeding studies confirm that irregular or consistently late eating shifts the phase of the skin peripheral clock and reduces the amplitude of core clock gene expression, affecting approximately 10% of the skin transcriptome. Metabolic chronodisruption is the concept that connects the Randle Cycle entity, the Skin Circadian Clock entity, and the clinical presentation of skin that fails to respond to treatment as its surface appearance would predict.

The NAD⁺ Circadian Oscillation

The molecular clock in a skin cell runs on chemistry as much as genetics. The CLOCK:BMAL1 heterodimer does not simply produce the transcription-translation feedback loop described in the Skin Circadian Clock entity – it also drives transcription of NAMPT ( nicotinamide phosphoribosyltransferase), the rate-limiting enzyme in the NAD⁺ salvage pathway. Two concurrent papers – Nakahata et al. in Science and Ramsey et al. in Science, both published in 2009 – independently established that intracellular NAD⁺ levels oscillate on a 24-hour cycle driven by this clock-regulated NAMPT expression. NAD⁺ rises as CLOCK:BMAL1 drives NAMPT transcription; it falls as that drive recedes through the repressive phase of the cycle. The chemical clock runs in parallel with the genetic one. ^{[3] [4]}

What makes this loop genuinely interlocked rather than simply sequential is that SIRT1 is recruited to the Nampt promoter and contributes to the transcriptional activity that generates its own coenzyme. The architecture is circular: CLOCK:BMAL1 drives NAMPT, NAMPT drives NAD⁺, NAD⁺ fuels SIRT1, and SIRT1 sustains BMAL1 activity through deacetylation. When metabolic conditions support adequate NAD⁺ availability, this cycle reinforces the clock’s precision and amplitude. When conditions deplete NAD⁺, the cycle loses amplitude from the inside of its own feedback architecture – not from external disruption but from chemical starvation of the mechanism that sustains it.

SIRT1 – The Molecular Bridge Between Metabolic State and Clock Amplitude

SIRT1 is a histone deacetylase that requires NAD⁺ as an obligate coenzyme. Without it, SIRT1 cannot produce catalytic output – it cannot remove acetyl groups from its target proteins. Its clock role is to deacetylate BMAL1 and to regulate PER2 subcellular behaviour, both of which are necessary for maintaining the amplitude and phase precision of the primary transcription-translation feedback loop.

Research from the Nara Institute of Science and Technology, published in Frontiers in Neuroscience (2021), directly measured what happens to the clock when cellular NAD⁺ is reduced by inhibiting NAMPT pharmacologically – a condition the authors characterised as mimicking “aged or pathophysiological conditions.” ^[1] Under low NAD⁺:

• The amplitude of BMAL1 promoter-driven luciferase oscillation was measurably attenuated
• PER2 mislocalised from nucleus to cytoplasm at significantly elevated rates – nuclear PER2 fell from 49.3% to 34.5%; cytoplasmic PER2 rose from 18.8% to 32.0%
• CRY1 localisation followed PER2, weakening the CRY/PER-dependent repression of CLOCK:BMAL1 target genes and producing elevated E-box-regulated gene expression
• Bmal1 transcript itself was reduced, whilst Rev-erbα/β were elevated – a pattern that compound-reduces BMAL1 activity through the stabilising loop as well as the primary loop
• Co-treatment with NMN (nicotinamide mononucleotide, an NAD⁺ precursor) fully reversed all three effects

Importantly, SIRT1 inhibitors alone replicated the amplitude attenuation and PER2 mislocalisation. PARP1 inhibition had no equivalent effect. This directly established that the NAD⁺/SIRT1 axis is the operative regulator of PER2 subcellular localisation and of circadian oscillation amplitude – not NAD⁺ depletion acting through some other NAD⁺-dependent enzyme.

Clinical Pearl: NAD⁺ depletion does not stop the clock. It reduces its amplitude – producing a cell that technically still oscillates but whose circadian-gated outputs become progressively weaker and less phase-precise. The downstream consequences for ceramide synthesis timing, collagen metabolism, and DNA repair emerge from amplitude reduction, not from clock arrest. This is clinically important because a dampened clock can appear to be functioning whilst its tissue-level outputs – barrier integrity, collagen architecture, repair efficiency – are meaningfully impaired.

The Randle Cycle Connection – How the Metabolic Impasse Depletes NAD⁺

The Randle Cycle establishes that when fatty acids are being oxidised, the initial biochemical event – stated explicitly in Hue and Taegtmeyer’s 2009 review – is “an increase in the mitochondrial ratios of acetyl-CoA/ CoA and NADH/NAD.” ^[2] The NAD⁺/NADH ratio falls as NADH accumulates. This is not a peripheral detail: it is the mechanistic centrepiece of fatty acid-mediated glucose suppression, because accumulated NADH directly inhibits pyruvate dehydrogenase and contributes to the citrate accumulation that propagates through glycolytic inhibition.

In the metabolic impasse – the simultaneous high-glucose and high-fat state characteristic of ultra-processed food consumption – NADH accumulates from two concurrent sources. Partial β-oxidation of fatty acids unable to complete mitochondrial entry (CPT-1 inhibited by malonyl-CoA from glucose-driven insulin) generates NADH without clean cycling. Glycolytic flux from elevated glucose simultaneously adds NADH to the cytosolic pool. Neither fuel is being handled cleanly; both are contributing to NADH accumulation in a cellular environment where oxidative phosphorylation is already saturated. Research in metabolically compromised tissues documents the downstream consequence as “pseudohypoxia” – a state in which the cytosolic NAD⁺/NADH ratio falls because substrate supply exceeds the cell’s capacity to regenerate NAD⁺ through the electron transport chain. NAMPT activity and NAD⁺ biosynthesis are themselves impaired in insulin-resistant and obese states, compounding the depletion that the metabolic impasse initiates.

The pathway from metabolic inflexibility to clock amplitude reduction runs through independently confirmed links:

Metabolic impasse → NADH accumulation → NAD⁺/NADH ratio falls → SIRT1 activity stalls → BMAL1 oscillation amplitude dampens → clock-gated skin functions lose temporal precision

No single paper demonstrates this complete chain in skin cells specifically. Each link is confirmed in primary research; the synthesis across them is mechanistically coherent rather than directly evidenced as a unified skin mechanism. This is noted in the evidence calibration section. The distinction matters for accuracy – this discussion rests on a mechanistic argument that is considerably stronger than speculation but should not be presented as a single-paper finding.

What the Randle Cycle mechanism alone does not explain is why the metabolic impasse is recreated consistently and repeatedly in the clients most likely to present with metabolic chronodisruption. The cellular biochemistry describes what happens when high glucose and high fat arrive simultaneously; it does not explain why they arrive simultaneously day after day in the same individual. The Food Addiction entity provides that explanation: the mesolimbic dopamine circuit, FosB accumulation, and DRD2 downregulation that characterise food addiction specifically target hyperpalatable fat-sugar combination UPFs – the exact macronutrient profile that most efficiently creates the impasse. In clients where compulsive dietary behaviour is a factor, metabolic chronodisruption is not an episodic consequence of occasional dietary choices; it is a sustained structural condition driven by the neurobiological architecture described in the Food Addiction entity. This is clinically relevant to treatment planning conversations: addressing the metabolic impasse in these clients requires understanding that it is being recreated continuously by a reward-circuit dynamic that dietary advice alone does not resolve.

What the Clock Loses – Downstream Skin Failures

When BMAL1 oscillation amplitude dampens, three primary clock-gated skin functions are affected at the molecular level of their timing mechanism.

The temporal architecture of collagen metabolism

A 2026 study in the Journal of Cosmetic Dermatology (Wang et al., Tongji University and Fudan University) used a dexamethasone-synchronised human skin fibroblast model to map the circadian expression of genes governing every stage of collagen metabolism. ^[5] The findings were more precise than the commonly assumed “collagen is made at night” simplification. Genes involved in collagen synthesis and secretion (Sec61a2, Mia3, Pde4d, Vps33b) and collagen degradation (MMP1, cathepsin K) peak during the nighttime phase. Genes involved in collagen fibril assembly and cross-linking (LOX, lysyl oxidase) peak during the daytime phase.

The biological logic is coherent: the cell synthesises and secretes new collagen material at night, then cross-links and assembles it into organised fibrils during the day. These are not simultaneous processes – the clock sequences them. The same paper references that BMAL1 regulates this collagen expression cycle via the SIRT1 pathway, consistent with the ARD 2017 fibroblast research showing that BMAL1 knockdown reduces SIRT1 expression and elevates MMP-driven matrix degradation.

When the BMAL1-SIRT1 axis amplitude is reduced by NAD⁺ depletion, this temporal sequencing breaks down. The result is not simply less collagen – it is loss of the timing relationship between synthesis and assembly, and a weakening of SIRT1-mediated MMP suppression during the assembly phase. Collagen architecture becomes disordered as synthesis and degradation run without their normal phase separation. This connects directly to the Collagen page’s observation that photoaged and metabolically ageing skin shows structurally disorganised fibril architecture, not only quantitative collagen loss.

Ceramide synthesis de-phasing

The ROR pathway – which gates ceramide synthesis through the CLOCK:BMAL1 stabilising loop and whose disruption produces the specific barrier dysfunction phenotype documented in the Skin Circadian Clock – depends on the oscillatory drive of BMAL1 activity for its circadian expression. A reduction in BMAL1 amplitude does not silence ROR expression; it weakens the phase-gating that makes ceramide synthesis preferentially active during the nighttime window. Ceramide production does not stop – its temporal precision is lost. Barrier function becomes less reliably reinforced at night, and the persistent reactive barrier pattern that topical support alone cannot correct whilst the metabolic disruption continues reflects this clock-level timing failure rather than a simple deficiency in ceramide substrate or synthesis enzyme availability.

XPA repair efficiency drift

The XPA loop operates through protein stability via the HERC2 ubiquitin ligase mechanism, which provides some resistance to transcriptional clock amplitude reduction. However, when BMAL1 amplitude reduction is sustained and multiple entrainment signals are producing incoherent phase information – as occurs when both the feeding zeitgeber and metabolic state are disrupted simultaneously – XPA peak timing can shift relative to the sleep window. The specific metabolic route to XPA phase drift involves more inferential steps than the collagen and ceramide mechanisms, and this is reflected in the evidence calibration table below.

Feeding Timing as a Direct Skin Clock Variable

The practical significance of this entity depends partly on a 2017 Cell Reports study (Wang, Geyfman et al., University of California, Irvine and UT Southwestern) that is among the most directly relevant pieces of skin clock research for client conversations. ^[6] The study examined five different time-restricted feeding schedules in mice and found that:

• Time-restricted feeding shifts the phase of core skin clock genes – Per2, Per1, and Dbp – with daytime-fed mice showing phase shifts of up to 4–5 hours compared to night-fed controls
• Daytime-fed mice showed significantly lower amplitude of Per2 expression than night-fed mice; this amplitude reduction in the skin was distinct from the liver, where feeding timing is a more direct and dominant zeitgeber
• Feeding schedule dictated the diurnal expression of approximately 10% of the skin transcriptome, with the specific genes affected varying by schedule whilst functional categories – circadian clock, redox regulation, cell cycle – were conserved across schedules
• Xpa expression was dampened and less rhythmic under all time-restricted feeding schedules compared to ad libitum night-time feeding, with daytime feeding reversing the diurnal pattern of UVB-induced DNA damage sensitivity

The paper also found that food intake acutely regulates approximately 2,000 skin genes within hours of eating – most prominently metabolic genes – with the skin transcriptome shifting from an oxidative fasting profile (fatty acid oxidation, autophagy, stress response) to an anabolic post-meal profile ( lipid biosynthesis, protein synthesis) in response to feeding. Skin metabolism at the transcriptional level is responsive to when food arrives, independently of what that food contains.

This creates a two-mechanism model for metabolic chronodisruption that is important for clinical conversations because the two mechanisms operate independently and can compound:

A client who eats late consistently receives the phase-displacement mechanism. A client who eats in the ultra-processed food pattern – high fat and high sugar delivered simultaneously – receives the metabolic amplitude reduction mechanism. A client who does both receives both simultaneously. And because the skin clock’s response to feeding is distinct from the liver’s, normalising either without addressing the other produces only partial correction.

Evidence Calibration